All In MedTech

FDA Clearance Tracker · P030050-S001

SCULPTRA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 11, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 11, 2005

Approved

Time to decision

189 days

Received Oct 4, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030050-S001
Device name
SCULPTRA
Applicant
Q-Med AB
Applicant location
Uppsala
Received
Oct 4, 2004
Decided
Apr 11, 2005
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P030050

Device type

Device class
Class III

Every decision under product code LMH

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY FOR THE DEVICE.

Source documents

Other decisions for Q-Med AB

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.